<qa>  What is the study that explores efficacy of intensive rosuvastatin treatmentThis is a 30-day, randomized, open-label, 3-arm, parallel-group, multicenter study exploring efficacy of intensive rosuvastatin treatment peri-PCI in Chinese patients with NSTE-ACS. 